Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 37 Issue 6
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2019  >  37(6): 548-551,570

LI Ruimin, SUN Xiaohong, YANG Zhangwei, SHU Lixin. Selection method and supervision strategy of key monitoring drug list of multi-center hospital in certain region[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 548-551,570. doi: 10.3969/j.issn.1006-0111.2019.06.015
Citation: LI Ruimin, SUN Xiaohong, YANG Zhangwei, SHU Lixin. Selection method and supervision strategy of key monitoring drug list of multi-center hospital in certain region[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 548-551,570. doi: 10.3969/j.issn.1006-0111.2019.06.015
shu

Selection method and supervision strategy of key monitoring drug list of multi-center hospital in certain region

doi: 10.3969/j.issn.1006-0111.2019.06.015
  • 1.

    Department of Military Medical Supply Administration, School of Pharmacy, Naval Medical University, Shanghai 200433, China

  • 2.

    Medicine and Equipment Supply Station of No. 32653 Unit of PLA, Shenyang 110026, China

  • 3.

    Department of Information, Fourth Peoples'Hospital Affiliated to Tongji University, Shanghai 200081, China

  • Received Date: 2019-06-12
  • Rev Recd Date: 2019-08-20
  • Objective To reduce the unreasonable medical expenditure and improve the level of clinical rational drug by strengthening the supervision of adjuvant drug use. Methods The regionally integrated medical database and standardized basic drug information database were used.The market share of adjuvant drugs varieties and their clinical consumption of multi-center hospital in certain region were collected and analyzed.The data of 2015 and 2018 after the implementation of supervision were compared. Results The monitoring results of clinical application adjuvant drugs in nearly 200 hospitals of the region were obtained.The selection method of key monitoring drug list based on the medical big data was discussed after expert review.The first batch of 80 drugs in the key monitoring of regional medical institutions was confirmed.Improper use of key clinical monitoring drugs had been improved. Conclusion Through the introduction of relevant policies by the state and the implementation of rectification measures in various regions,the unreasonable use of key monitoring drugs had been improved to some extent.
  • [1] 国家卫健委.关于印发第一批国家重点监控合理用药药品目录(化药及生物制品)的通知.(2019-07-01)[2019-08-11].http://www.nhc.gov.cn/yzygj/s7659/201907/d356ce8a4ba1461ca66c544724dffc5e.shtml.
    [2] 王辉,刘正跃,孙国权,等.110所医院Ⅰ类切口手术抗菌药物预防使用率的综合评价[J].中国药学杂志,2016,51(15):1336-1340.
    [3] 王辉,杨樟卫,毛旭峰,等.基于区域医疗大数据构筑合理用药监测生态系统[J].药学服务与研究,2018,18(6):419-423.
    [4] 孙国权,舒丽芯,王晓娟,等.基于医疗大数据的创伤住院患者抗菌药物使用研究[J].药学实践杂志,2017,35(5):466-471.
    [5] 王辉,谢欣苇,刘正跃,等.156所综合性医院住院患者静脉输液指标的综合分析[J].药学实践杂志,2017,35(6):573-576.
    [6] 梁广楷,扶宇,李俊蕾,等.重点监控药品政策对样本地区辅助用药使用的影响研究[J].中国药学杂志,2018,53(18):1613-1618.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(3473) PDF downloads(815) Cited by()

Related
Proportional views

Selection method and supervision strategy of key monitoring drug list of multi-center hospital in certain region

doi: 10.3969/j.issn.1006-0111.2019.06.015
  • 1. Department of Military Medical Supply Administration, School of Pharmacy, Naval Medical University, Shanghai 200433, China
  • 2. Medicine and Equipment Supply Station of No. 32653 Unit of PLA, Shenyang 110026, China
  • 3. Department of Information, Fourth Peoples'Hospital Affiliated to Tongji University, Shanghai 200081, China
  • Received Date: 2019-06-12
  • Rev Recd Date: 2019-08-20

Abstract: Objective To reduce the unreasonable medical expenditure and improve the level of clinical rational drug by strengthening the supervision of adjuvant drug use. Methods The regionally integrated medical database and standardized basic drug information database were used.The market share of adjuvant drugs varieties and their clinical consumption of multi-center hospital in certain region were collected and analyzed.The data of 2015 and 2018 after the implementation of supervision were compared. Results The monitoring results of clinical application adjuvant drugs in nearly 200 hospitals of the region were obtained.The selection method of key monitoring drug list based on the medical big data was discussed after expert review.The first batch of 80 drugs in the key monitoring of regional medical institutions was confirmed.Improper use of key clinical monitoring drugs had been improved. Conclusion Through the introduction of relevant policies by the state and the implementation of rectification measures in various regions,the unreasonable use of key monitoring drugs had been improved to some extent.

LI Ruimin, SUN Xiaohong, YANG Zhangwei, SHU Lixin. Selection method and supervision strategy of key monitoring drug list of multi-center hospital in certain region[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 548-551,570. doi: 10.3969/j.issn.1006-0111.2019.06.015
Citation: LI Ruimin, SUN Xiaohong, YANG Zhangwei, SHU Lixin. Selection method and supervision strategy of key monitoring drug list of multi-center hospital in certain region[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 548-551,570. doi: 10.3969/j.issn.1006-0111.2019.06.015
shu

    HTML

Reference (6)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return